If lymph node involvement is confirmed in the affected individual undergoing neoadjuvant therapy that is a possible applicant for qualified axillary dissection (TAD), a marker ought to be inserted while in the lymph node immediately after biopsy. Không để sản phẩm tiếp xúc trực tiếp với ánh nắng mặt https://waldoq753ufo4.wikirecognition.com/user